A Phase 2 Multicenter Study Evaluating The Efficacy Of KTE-C19 In Subjects With Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Read more
Extended Treatment Protocol For Subjects Continuing To Benefit From Ibrutinib After Completion Of Ibrutinib Clinical Trials Read more
Clinical Efficacy And Mechanisms Of Resistance To Polatuzumab Vedotin In Patients With Large B-Cell Lymphoma After CAR T-Cell Therapy Read more
Prospective Multicenter International Observational Study For Determination Of A Cutaneous Lymphoma International Prognostic Index Model And Impact Of Major Therapies In Patients With Advanced Mycosis Fungoides And Sézary Syndrome Advanced Stage PROCLIPI Project By The Cutaneous Lymphoma International Consortium (CLIC) Collaborative Alliance Read more
Outcomes Of Patients With Aggressive B-Cell Non-Hodgkin S Lymphoma Who Undergo Hematopoietic Cell Transplantation After CAR T-Cell Therapy Read more
A Phase 2 Study Of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, And Prednisone (CHEP-BV) Followed By BV Consolidation In Patients With CD30-Positive Peripheral T-Cell Lymphomas Read more
A Phase 2 Front-Line PET/CT-2 Response-Adapted Brentuximab Vedotin And Nivolumab Incorporated And Radiation Free Management Of Early Stage Classical Hodgkin Lymphoma (Chl) Read more
